Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 9, 154 (2003)
doi:10.1038/nm0203-154a
Europe dithers over stem cell patents
Peter Mitchell1
- London
The European Commission may restrict the scope of stem cell technology patents, to encourage faster development of stem cell–based therapeutics while placating ethically motivated campaigners.In November, the Commission published a report admitting considerable uncertainty over which aspects of stem cell technology could be patented and how wide the patents should be.
To read this story in full you will need to login or make a payment (see right).
